Although FEZF1-AS1 expression is known to be associated with poor prognosis in several types of cancers including GC (Wu et al., 2017; Zhou et al., 2019; Chen et al., 2021), its role in MDR of GC cells remains unknown. This evidence concerns the gene FEZF1 and gastric cancer.